Aristotle Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oshkosh
OSK
|
+$127M |
| 2 |
Banco Santander
SAN
|
+$52.3M |
| 3 |
AbbVie
ABBV
|
+$36.1M |
| 4 |
Diageo
DEO
|
+$30.9M |
| 5 |
UN
Unilever NV New York Registry Shares
UN
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bunge Global
BG
|
+$98.9M |
| 2 |
Vodafone
VOD
|
+$88.1M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$6.96M |
| 4 |
Lumen
LUMN
|
+$6.42M |
| 5 |
Willis Towers Watson
WTW
|
+$3.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.87% |
| 2 | Technology | 13.73% |
| 3 | Consumer Discretionary | 12.95% |
| 4 | Healthcare | 11.99% |
| 5 | Industrials | 11.42% |
Similar funds
Aristotle Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Aristotle Capital Management held 141 positions worth $6.29B, up 26% from $4.99B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Aristotle Capital Management deployed $843M of net new capital in Q4 2013, opening 7 new positions and adding to 80 existing holdings. Its largest new stake was Oshkosh: 2,543,807 shares worth $128M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bunge Global, an estimated $98.9M trimmed.
- Aristotle Capital Management's largest Q4 2013 buy was Oshkosh: 2,543,807 shares worth $128M.
- Aristotle Capital Management added most to Banco Santander in Q4 2013, an estimated $52.3M increase.
- Aristotle Capital Management's biggest Q4 2013 reduction was Bunge Global, cutting an estimated $98.9M.
- Aristotle Capital Management fully exited Vodafone in Q4 2013, selling an estimated $88.1M.
- Aristotle Capital Management's ten largest holdings make up 29% of its $6.29B portfolio in Q4 2013.
- Aristotle Capital Management opened 7 new positions and closed 6 in Q4 2013.
- Aristotle Capital Management's portfolio value rose 26% quarter-over-quarter to $6.29B.
Based on Aristotle Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.